SCHEMBL5771897

SCHEMBL5771897

COc1cc(N(C(C)=O)c2cccc(NC(=O)c3cn(C(C)(C)C)nc3-c3cc(F)ccc3Cl)c2)cc(OC)c1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
SMO Q99835 1/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.36
GRM4 Q14833 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
DHODH Q02127 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6697312 0.89 FYN (0.38) PDE7ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7499774 0.84 PTGS2 (0.37) PDE7ANPC1RAB9ASMN1; SMN2TP53
SCHEMBL5771902 0.82 SMN1; SMN2 (0.48) PDE7ASMN1; SMN2KDM4EMAPTLMNA
SCHEMBL5770736 0.78 PTGS2 (0.44) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL6691783 0.70 PTGS2 (0.39) SMN1; SMN2TP53MAPTLMNASMO
SCHEMBL22095084 0.64 MEN1 (0.60) NPC1RAB9ATP53KDM4EMAPT
SCHEMBL5778310 0.64 POLB (0.51) SMN1; SMN2MAPTLMNA
SCHEMBL5773731 0.63 PTGS2 (0.51) SMN1; SMN2TP53KDM4EMAPTLMNA
SCHEMBL5774424 0.62 POLB (0.46) SMN1; SMN2KDM4EMAPTLMNAMEN1
SCHEMBL6692596 0.62 BRAF (0.40) SMN1; SMN2MAPTMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224189-B1 CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 LILLY CO ELI (US) 2006-01-25 EP disclosed
US-6670373-B1 Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide ELI LILLY AND COMPANY 2003-12-30 US disclosed